that the reason why they are not presenting sg110 at asco because they know they are being bought out or a merger and their is no reason to present it ??? i dont know im just asking a hypothetical question
I don't see that as possible at all. If this were true, it would be a violation of their fiduciary duty to shareholders to withhold any information that could enhance the price they would get in a buyout or partnership.
They said in the conference call that ASH and ASCO were so close together they didn't make a submission for ASCO,
Could be. They first said that the data was not mature enough to present at ASCO but would be presented at other conferences. The slide deck from Tuesday did not contain a 2013 event for SGI-110 phase 2 data presentation from what i recall. I could not print the slide deck.
they specifically answered that during the q&a after the conference call. data was not ripe enough and submissions were due in February, so just bad timing. there was nothing new that wasn't presented recently at AACR which was the reason for the run up in the first place.
a few weeks ago someone asked about a good entry point and, this was while we were in the low $6 range, I said i expected a pullback to $5.70. Well, today it got close and then finished strong (despite the big drop). we'll see where tomorrow takes us. Soon the cramerites will go to the next piece of meat he dangles in front of their faces and we will look to break that $6.90 resistance.